In this issue of Blood, Wagener et al demonstrate a new World Health Organization (WHO) provisional entity of MYC – Burkitt-like lymphoma (BLL) with 11q aberrations (mnBLL, 11q,) that is… Click to show full abstract
In this issue of Blood, Wagener et al demonstrate a new World Health Organization (WHO) provisional entity of MYC – Burkitt-like lymphoma (BLL) with 11q aberrations (mnBLL, 11q,) that is distinct from MYC + sporadic Burkitt lymphoma (BL) as well as other germinal center–derived B-cell lymphomas, including follicular lymphoma and diffuse large B-cell lymphoma. 1
               
Click one of the above tabs to view related content.